Cafestol, a coffee-specific diterpene, induces peripheral antinociception mediated by endogenous opioid peptides

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 5, 2012, Pages 412-416

  Guzzo, Luciana S ^a   Perez, Andrea C ^a   Romero, Thiago R L ^a   Azevedo, Adolfo O ^b   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b University Center of Lavras (UNILAVRAS)   (Brazil)

Author keywords

Cafestol; Opioid; Peripheral antinociception

Indexed keywords

BESTATIN; CAFESTOL; NALOXONE; OPIATE PEPTIDE; PROSTAGLANDIN E2;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COFFEE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; HINDLIMB; HYPERALGESIA; MALE; NONHUMAN; PAIN THRESHOLD; PRESSURE MEASUREMENT; RAT; TREATMENT RESPONSE;

ANIMALS; COFFEE; DITERPENES; HYPERALGESIA; MALE; OPIOID PEPTIDES; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 84860249984     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05689.x     Document Type: Article

References (30)

1. Bellisle F, Blundell JE, Dye L, et al. Functional food science and behaviour and psychological functions. Br. J. Nutr. 1998; 80: S173-93.
2. Reilly C. Functional foods: A challenge for consumers. Trends Food Sci. Technol. 1994; 7: 327-32.
3. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem. Toxicol. 1997; 35: 547-54.
4. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 1997; 17: 305-24.
5. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem. Toxicol. 2002; 40: 1155-63.
6. Huber WW, Rossmanith W, Grusch M, et al. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem. Toxicol. 2008; 46: 1230-8.
7. Huber WW, Prustomersky S, Delbanco E, et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch. Toxicol. 2002; 76: 209-17.
8. 2+ dependent process. Prostaglandins 1979; 18: 179-90.
9. Kim JY, Jung KS, Jeong HG. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett. 2004; 569: 321-6.
10. Kim JY, Kim DH, Jeong HG. Inhibitory effect of the coffee diterpene kahweol on carrageenan-induced inflammation in rats. BioFactors 2006; 26: 17-28.
11. Randall LO, Sellito JJ. A method for measurement of analgesic activity on inflamed tissues. Arch. Int. Pharmacodyn. 1957; 11: 409-19.
12. Green AF, Young PA. A comparison of heat and pressure analgesiometric methods in rats. Br. J. Pharmacol. 1951; 6: 572-85.
13. 2C-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine. Eur. J. Pharmacol. 2009; 608: 23-7.
14. Reis GML, Pacheco D, Perez AC, Klein A, Ramos MA, Duarte IDG. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide. Life Sci. 2009; 85: 351-6.
15. Romero TRL, Galdino GS, Silva GC, et al. Ketamine activates the l-arginine/nitrous oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats. Anesth. Analg. 2011; 113: 1254-9.
16. França DS, Ferreira-Alves DL, Duarte ID, et al. Endogenous opioids mediate the hypoalgesia induced by inhibitors of cyclooxygenase-2 in rat paws treated with carrageenan. Neuropharmacology 2006; 5: 37-43.
17. Nakamura M, Ferreira HS. Peripheral analgesic action of clonidine: Mediation by release of endogenous enkephalin-like substances. Eur. J. Pharmacol. 1988; 146: 223-8.
18. Nakamura M, Lico MC. Peripheral modulation of pain in conscious guinea pigs: Effect of morphine, nalorphine and clonidine. Braz. J. Med. Biol. Res. 1988; 21: 577-83.
19. Khodorova A, Fareed MU, Gokin A, Strichartz GR, Davar G. Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner. J. Neurosci. 2002; 22: 7788-96.
20. Parsons CG, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress. J. Pharmacol. Exp. Ther. 1990; 255: 795-802.
21. Suh HH, Tseng LL. Intrathecal administration of thiorphan and bestatin enhances the antinociception and release of Met-enkephalin induced by beta-endorphin intraventricularly in anesthetized rats. Neuropeptides 1990; 16: 91-6.
22. Stein C, Schäfer M, Machelska H. Attacking pain at its source. New perspectives on opioids. Nat. Med. 2003; 9: 1003-8.
23. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception. Neuroscience 1992; 48: 491-500.
24. Stein C, Ahmed HSH, Schäfer M. Peripheral opioid receptors. Ann. Med. 1995; 27: 219-21.
25. Stein C, Ahmed HSH, Ryszard P, Christian G, Klaus P, Albert H. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl Acad. Sci. USA 1990; 87: 5935-9.
26. 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl Acad. Sci. USA 2005; 102: 3093-8.
27. Khodorova A, Navarro B, Jouaville LS, et al. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med. 2003; 9: 1055-61.
28. Tominaga M, Ogawa H, Takamori K. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J. Invest. Dermatol. 2007; 127: 2228-35.
29. Antonijevic I, Mousa SA, Schäfer M, Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 1995; 15: 165-72.
30. Chen JJ, Dymshitz J, Vasko MR. Regulation of opioid receptors in rat sensory neurons in culture. Mol. Pharmacol. 1997; 51: 666-73.